Correlation Between MediciNova and Vor Biopharma

Can any of the company-specific risk be diversified away by investing in both MediciNova and Vor Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Vor Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MediciNova and Vor Biopharma, you can compare the effects of market volatilities on MediciNova and Vor Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Vor Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Vor Biopharma.

Diversification Opportunities for MediciNova and Vor Biopharma

0.28

Correlation Coefficient

MediciNova  Vor Biopharma

Modest diversification

The 3 months correlation between MediciNova and Vor is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Vor Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vor Biopharma and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Vor Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vor Biopharma has no effect on the direction of MediciNova i.e., MediciNova and Vor Biopharma go up and down completely randomly.

Pair Corralation between MediciNova and Vor Biopharma

Given the investment horizon of 90 days MediciNova is expected to generate 0.68 times more return on investment than Vor Biopharma. However, MediciNova is 1.47 times less risky than Vor Biopharma. It trades about 0.0 of its potential returns per unit of risk. Vor Biopharma is currently generating about -0.02 per unit of risk. If you would invest  240.00  in MediciNova on October 23, 2024 and sell it today you would lose (57.00) from holding MediciNova or give up 23.75% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	99.8%
Values	Daily Returns

MediciNova  vs.  Vor Biopharma

MediciNova

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.

Vor Biopharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Vor Biopharma are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Vor Biopharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with MediciNova and Vor Biopharma

The main advantage of trading using opposite MediciNova and Vor Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Vor Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will offset losses from the drop in Vor Biopharma's long position.

The idea behind MediciNova and Vor Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.